Jazz Pharmaceuticals Aktie
116,15
EUR
+1,70
EUR
+1,49
%
137,01
USD
+3,77
USD
+2,83
%
Werbung
Jazz Pharmaceuticals Aktie Analyse
| 14.12.18 | Jazz Pharmaceuticals Peer Perform | Wolfe Research | |
| 23.03.18 | Jazz Pharmaceuticals Neutral | H.C. Wainwright & Co. | |
| 05.12.17 | Jazz Pharmaceuticals Neutral | Mizuho | |
| 10.11.17 | Jazz Pharmaceuticals Neutral | H.C. Wainwright & Co. | |
| 25.08.17 | Jazz Pharmaceuticals Neutral | H.C. Wainwright & Co. | |
| 31.05.17 | Jazz Pharmaceuticals Neutral | Mizuho | |
| 06.04.17 | Jazz Pharmaceuticals Neutral | Mizuho | |
| 24.02.16 | Jazz Pharmaceuticals Neutral | Mizuho | |
|
Werbung
|
|||
| 10.11.15 | Jazz Pharmaceuticals Neutral | Mizuho | |
Werbung
Werbung